British Journal of Haematology

Papers
(The H4-Index of British Journal of Haematology is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
e‐Posters144
CAR T in patients with large B‐cell lymphoma not fit for autologous transplant119
Graham Serjeant, Sickle Cell, Jamaica and Beyond: A Life, Ian Randle Publishers (Kingston and Miami), 2021114
Functional impairment of erythropoiesis in Congenital Dyserythropoietic Anaemia type I arises at the progenitor level87
Guideline for the diagnosis and management of marginal zone lymphomas: A British Society of Haematology Guideline84
COSMIC, chemotherapy plus ofatumumab at standard or mega‐dose in chronic lymphocytic leukaemia, a phase II randomised study81
A novel MYC–non‐IG fusion in refractory diffuse large B‐cell lymphoma75
Alternative donor transplantation for severe aplastic anaemia in 2021: haplo donor, cord blood or both?74
Myelodysplastic syndrome associated‐haemophagocytic lymphohistiocytosis: A retrospective study of 15 cases in a single centre73
Issue Information73
71
Don't forget cord blood in non‐remission acute myeloid leukaemia!70
Venous thromboembolism incidence associated with pegylated asparaginase (ASP) compared to the native L‐ASP: A retrospective analysis with an ASP‐based protocol in adult patients with acute lympho65
Issue Information62
Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma – A study from the Danish Lymphoma Registry59
Erythrophagocytosis in a patient with myelodysplastic syndrome with excess blasts‐1 with isolated del(6q)58
Use of dipyridamole is associated with lower risk of lymphoid neoplasms: a propensity score‐matched cohort study54
Issue Information53
Population‐based cohort study of the efficacy of brentuximab vedotin in relapsed systemic anaplastic large‐cell lymphoma using Public Health England data52
Whole‐exome sequencing uncovered genetic diagnosis of severe inherited haemolytic anaemia: Correlation with clinical phenotypes52
Applying current smouldering myeloma risk models to a UK single‐centre cohort and clinical features at progression50
Obinutuzumab as consolidation after chemo‐immunotherapy: Results of the UK National Cancer Research Institute phase II/III GALACTIC trial50
Stratified management based on surface antibody for the prevention of hepatitis B virus reactivation in lymphoma patients50
Correction to “Cytidine deaminase status as a marker of response to azacytidine treatment in MDS and AML patients”48
Association of biomarkers of endothelial function, coagulation activation and kidney injury with persistent albuminuria in sickle cell anaemia48
Management of immunosuppression in post‐transplant lymphoproliferative disorders treated with CAR T cells47
A 4‐gene prognostic index for enhancing acute myeloid leukaemia survival prediction46
Immunophenotypic clustering in paediatric acute myeloid leukaemia46
Management of luspatercept therapy in patients with transfusion‐dependent β‐thalassaemia45
ATG versus PTCy in matched unrelated donor haematopoietic stem cell transplantations with non‐myeloablative conditioning44
Venetoclax ramp‐up strategies for chronic lymphocytic leukaemia in the United Kingdom: a real world multicentre retrospective study43
Characterisation of two tumour cell populations in the small cell variant of anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma42
The impact of COVID‐19 vaccination on patients with a history of heparin‐induced thrombocytopenia41
Hepatic haemophagocytosis in haematology patients with hepatic dysfunction: prognostic impact and contribution of liver biopsy combined with the haemophagocytic syndrome diagnostic score (HScore)40
39
Issue Information38
Does eventually NPM1 mutation in blast phase chronic myeloid leukemia (BP‐CML) exist? That is the question.38
The oldest case of lymphoma? Insights from a XIII century fresco37
Indirect presentation of mismatched human leukocyte antigen‐B associates with outcomes of cord blood transplantation37
Non‐pharmacological supportive‐care interventions in acute myeloid leukaemia: a review of randomised controlled trials37
0.19724416732788